Gilead Targets Remdesivir Supply for Two Million Covid-19 Patients By Year-end

The company also said it hoped to start trials in August of an easier-to-use inhaled version of the medicine, currently administered only intravenously.

from Top World News- News18.com https://ift.tt/2CrHJsd